Log in to save to my catalogue

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoin...

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_68c745c8e80e44898d2db6645e7a63b2

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

About this item

Full title

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2022-03, Vol.10 (3), p.e004560

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity, use in clinical practice is heterogeneous. We aimed to develop expert recommendations to standardiz...

Alternative Titles

Full title

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_68c745c8e80e44898d2db6645e7a63b2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_68c745c8e80e44898d2db6645e7a63b2

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2022-004560

How to access this item